Carriers of mutations predicted to encode a full-length ATM protein had cancer risks similar to those of people carrying truncating mutations, predicting that both type of mutation in these families are pathogenic for ataxia-telangiectasia as well as for breast cancer [6,41]. The gene discussed is ATM; the disease is breast cancer.